Takashi Ichiyama

Shouichi Ohga1
Mitsuyoshi Ayabe1
Yuko Kitagawa1
Takuro Mizukami1
1Shouichi Ohga
1Mitsuyoshi Ayabe
1Yuko Kitagawa
1Takuro Mizukami
Learn More
BACKGROUND S-1 is an oral anticancer drug, containing tegafur (a prodrug of 5-fluorouracil, 5-FU), 5-chloro-2,4-dihydroxypyridine, and potassium oxonate. As renal dysfunction is known to increase exposure of 5-FU following S-1 administration, the incidence of severe adverse reactions is increased in patients with impaired renal function. However, no(More)
  • Shinji Maeba, Shunji Hasegawa, Maiko Shimomura, Takuya Ichimura, Kazumasa Takahashi, Masashi Motoyama +4 others
  • 2015
Background Herpes simplex virus (HSV) infection carries one of the poorest outcomes of neonatal liver failure (NLF). Neonates with disseminated HSV infection can develop hemophagocytic lymphohistiocytosis (HLH), and occasionally need orthotopic liver transplantation. Early interventions may be critical for the cure of NLF. Case Report We describe herewith a(More)
  • 1